| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Evoke Pharma, Inc.: Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference | 1 | GlobeNewswire (USA) | ||
| Mi | Evoke Pharma GAAP EPS of -$0.17 beats by $0.04, revenue of $1.73M misses by $0.41M | 2 | Seeking Alpha | ||
| Di | Evoke Pharma Inc reports results for the quarter ended in January - Earnings Summary | - | Reuters | ||
| Di | Evoke Pharma Inc - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| Di | Evoke Pharma, Inc.: Evoke Pharma Reports First Quarter 2024 Financial Results | 85 | GlobeNewswire (Europe) | 114% year-over-year increase in net product sales70% prescriber growth in Q1 2024 compared to Q4 2023Growing sales metrics reaffirms company's $14M net revenue guidance for 2024 SOLANA BEACH, Calif.... ► Artikel lesen | |
| Di | Evoke Pharma Inc - 10-K/A, Annual Report | 1 | SEC Filings | ||
| Di | Evoke Pharma Inc - 8-K, Current Report | 1 | SEC Filings | ||
| 17.04. | Evoke Pharma, Inc.: Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications | 5 | GlobeNewswire (USA) | ||
| 21.03. | Evoke Pharma names Matthew D'Onofrio as new CEO | 1 | Seeking Alpha | ||
| 21.03. | Evoke Pharma, Inc.: Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D'Onofrio to Chief Executive Officer | 419 | GlobeNewswire (Europe) | SOLANA BEACH, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with... ► Artikel lesen | |
| 21.03. | Evoke Pharma Inc - 8-K, Current Report | 1 | SEC Filings | ||
| 15.03. | Evoke Pharma, Inc. (EVOK) Q4 2023 Earnings Call Transcript | 1 | Insider Monkey | ||
| 14.03. | Evoke Pharma Inc reports results for the quarter ended in December - Earnings Summary | 1 | Reuters | ||
| 14.03. | Evoke Pharma GAAP EPS of -$0.59 revenue of $1.7M | 2 | Seeking Alpha | ||
| 14.03. | Recap: Evoke Pharma Q4 Earnings | 2 | Benzinga.com | ||
| 14.03. | Evoke Pharma, Inc.: Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results | 221 | GlobeNewswire (Europe) | Fiscal year 2023 net product sales from prescriptions totaled approximately $5.2M, a 107% increase from 2022 Company projects $14M in net revenue for 2024 SOLANA BEACH, Calif., March 14, 2024 (GLOBE... ► Artikel lesen | |
| 14.03. | Evoke Pharma Inc - 10-K, Annual Report | 1 | SEC Filings | ||
| 14.03. | Evoke Pharma Inc - 8-K, Current Report | 1 | SEC Filings | ||
| 13.03. | A Preview Of Evoke Pharma's Earnings | 2 | Benzinga.com | ||
| 07.03. | Evoke Pharma, Inc.: Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024 | 1 | GlobeNewswire (USA) |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 3.047 |
| EVOTEC | 2.410 |
| TUI | 1.919 |
| NEL | 1.222 |
| PLUG POWER | 1.035 |
| BAYER | 1.026 |
| NVIDIA | 1.005 |
| AMC ENTERTAINMENT | 982 |
| RHEINMETALL | 964 |
| SIEMENS ENERGY | 852 |
| DEUTSCHE BANK | 826 |
| RENK GROUP | 810 |
| REDCARE PHARMACY | 673 |
| COMMERZBANK | 645 |
| HEIDELBERGER DRUCK | 642 |
| ALIBABA | 635 |
| VOLKSWAGEN | 605 |
| E.ON | 561 |
| BYD | 525 |
| BARRICK GOLD | 523 |
| SIEMENS | 514 |
| RWE | 510 |
| AIXTRON SE | 503 |
| SFC ENERGY | 499 |
| DEUTSCHE LUFTHANSA | 497 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
